Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Moderna Inc (MRNA)

Moderna Inc (MRNA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 133,648,488
  • Shares Outstanding, K 405,450
  • Annual Sales, $ 803,400 K
  • Annual Income, $ -747,060 K
  • 60-Month Beta 1.32
  • Price/Sales 137.97
  • Price/Cash Flow N/A
  • Price/Book 10.95
Trade MRNA with:

Options Overview Details

View History
  • Implied Volatility 77.10%
  • Historical Volatility 124.37%
  • IV Percentile 76%
  • IV Rank 31.59%
  • IV High 131.61% on 12/01/20
  • IV Low 51.93% on 06/08/21
  • Put/Call Vol Ratio 0.30
  • Today's Volume 236,493
  • Volume Avg (30-Day) 116,977
  • Put/Call OI Ratio 0.82
  • Today's Open Interest 637,217
  • Open Int (30-Day) 570,862

Analyst Rating / Earnings Estimates

Current Rating
See More
Hold
Based on 13 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/21
See More
  • Average Estimate 8.44
  • Number of Estimates 8
  • High Estimate 10.27
  • Low Estimate 5.25
  • Prior Year -0.69
  • Growth Rate Est. (year over year) +1,323.19%

Price Performance

See More
Period Period Low Period High Performance
1-Month
210.96 +56.25%
on 11/05/21
353.28 -6.69%
on 10/28/21
-16.11 (-4.66%)
since 10/26/21
3-Month
210.96 +56.25%
on 11/05/21
464.85 -29.09%
on 09/10/21
-70.67 (-17.65%)
since 08/26/21
52-Week
102.66 +221.09%
on 12/31/20
497.49 -33.74%
on 08/10/21
+220.45 (+201.91%)
since 11/25/20

Most Recent Stories

More News
U.S. Stocks Settle Sharply Lower on New Covid Variant Concerns

What you need to know… The S&P 500 Index ($SPX ) (SPY ) on Friday closed down -2.27%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -2.53%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed...

$SPX : 4,594.62 (-2.27%)
SPY : 458.97 (-2.23%)
$DOWI : 34,899.34 (-2.53%)
DIA : 349.02 (-2.52%)
$IUXX : 16,025.58 (-2.09%)
QQQ : 391.20 (-1.90%)
UAL : 42.26 (-9.57%)
DAL : 36.38 (-8.34%)
AAL : 17.75 (-8.79%)
RCL : 67.98 (-13.22%)
NCLH : 20.06 (-11.36%)
CCL : 17.95 (-10.96%)
Delta, Carnival fall; Moderna, Clorox rise

Stocks that traded heavily or had substantial price changes Friday:

CCL : 17.95 (-10.96%)
MRNA : 329.63 (+20.57%)
CLX : 174.21 (+3.65%)
ZM : 220.21 (+5.72%)
OXY : 29.70 (-7.22%)
DAL : 36.38 (-8.34%)
Wall Street Tumbles on Resurgence of Coronavirus

Wall Street Tumbles on Resurgence of Coronavirus.

PFE : 54.00 (+6.11%)
UA : 20.63 (-3.37%)
MRNA : 329.63 (+20.57%)
TRIP : 26.75 (-5.18%)
NCLH : 20.06 (-11.36%)
ZM : 220.21 (+5.72%)
PTON : 46.41 (+5.67%)
BNTX : 348.00 (+14.19%)
U.S Stocks Slump as a New Covid Variant Darkens the Economic Outlook

What you need to know… The S&P 500 Index ($SPX ) (SPY ) this morning is down -1.75%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -2.56%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.87%....

$SPX : 4,594.62 (-2.27%)
SPY : 458.97 (-2.23%)
$DOWI : 34,899.34 (-2.53%)
DIA : 349.02 (-2.52%)
$IUXX : 16,025.58 (-2.09%)
QQQ : 391.20 (-1.90%)
UAL : 42.26 (-9.57%)
DAL : 36.38 (-8.34%)
AAL : 17.75 (-8.79%)
CCL : 17.95 (-10.96%)
RCL : 67.98 (-13.22%)
MAR : 147.44 (-6.45%)
Black Friday Meets "Black Friday:" New Covid Variant Hits Markets

A new Covid strain threatens the global marketplace anew, just as economic conditions around the world were beginning to get their footing following the Delta-variant fallout.

PFE : 54.00 (+6.11%)
UAL : 42.26 (-9.57%)
MRNA : 329.63 (+20.57%)
TRIP : 26.75 (-5.18%)
NCLH : 20.06 (-11.36%)
ZM : 220.21 (+5.72%)
PTON : 46.41 (+5.67%)
BNTX : 348.00 (+14.19%)
Pre-Market Brief: Stocks to Open Sharply Lower on a New Covid Variant

Morning Markets Dec S&P 500 futures this morning is down sharply by -1.71% at a 3-1/2 week low. Global stock and commodity markets are tumbling this morning on concern a new Covid variant identified in...

UAL : 42.26 (-9.57%)
DAL : 36.38 (-8.34%)
AAL : 17.75 (-8.79%)
CCL : 17.95 (-10.96%)
MAR : 147.44 (-6.45%)
DIDI : 7.88 (-2.84%)
CLF22 : 71.55 (+4.99%)
DVN : 42.70 (-5.30%)
BKR : 23.06 (-4.39%)
MRO : 15.70 (-6.71%)
OXY : 29.70 (-7.22%)
BAC : 45.76 (-3.93%)
Pfizer/BioNTech's COVID Jab Gets CHMP Nod for Kids Aged 5-11

Pfizer (PFE)/BioNTech (BNTX) COVID-19 vaccine, Comirnaty, if approved for use in children aged five to 11, will be the first vaccine to be approved for administration in this age group in Europe

JNJ : 159.20 (-0.65%)
PFE : 54.00 (+6.11%)
MRNA : 329.63 (+20.57%)
BNTX : 348.00 (+14.19%)
J&J (JNJ) Gets First Full Approval for COVID Jab in Canada

Canada grants full approval to J&J's (JNJ) COVID vaccine, making it the first full approval for the vaccine globally.

JNJ : 159.20 (-0.65%)
PFE : 54.00 (+6.11%)
MRNA : 329.63 (+20.57%)
BNTX : 348.00 (+14.19%)
EU regulator authorizes Pfizer's COVID vaccine for kids 5-11

THE HAGUE, Netherlands (AP) — The European Union's drug regulator on Thursday authorized Pfizer’s vaccine for use on children from 5 to 11 years old, clearing the way for shots to be administered...

$SPX : 4,594.62 (-2.27%)
$DOWI : 34,899.34 (-2.53%)
$IUXX : 16,025.58 (-2.09%)
MRNA : 329.63 (+20.57%)
PFE : 54.00 (+6.11%)
A Battle Plan Against High Inflation

How can investors navigate inflation and still see returns?

MRNA : 329.63 (+20.57%)
XOM : 61.25 (-3.51%)
CVX : 114.51 (-2.29%)
COP : 71.48 (-4.48%)
ENB : 38.99 (-2.28%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 32% Buy with a Weakening short term outlook on maintaining the current direction.

The market is approaching overbought territory. Be watchful of a trend reversal.

See More Share

Business Summary

Moderna Inc. is a clinical stage biotechnology company pioneering messenger RNA therapeutics and vaccines for patients. The company's product pipeline which is in clinical stage consists of mRNA-1647 for Cytomegalovirus Infectious Disease, mRNA-4157 for Solid tumors, mRNA-2416 for lymphoma and mRNA-...

See More

Key Turning Points

3rd Resistance Point 386.00
2nd Resistance Point 368.08
1st Resistance Point 348.85
Last Price 329.63
1st Support Level 311.70
2nd Support Level 293.78
3rd Support Level 274.55

See More

52-Week High 497.49
Fibonacci 61.8% 346.66
Last Price 329.63
Fibonacci 50% 300.08
Fibonacci 38.2% 253.49
52-Week Low 102.66

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar